| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 350MM | +5% |
| Gross Profit | -8.3MM | - |
| Cost Of Revenue | 358.3MM | -1% |
| Operating Income | 111.4MM | +28% |
| Operating Expenses | -119.7MM | - |
| Net Income | 90.1MM | +20% |
| G&A | 100.4MM | +1% |
| Interest Expense | 342K | -23% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
CINCINNATI, April 24, 2024--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2024, versus the comparable prior-year period.
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.
CINCINNATI, April 17, 2024--VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. The transaction is structured as an asset purchase.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. Global equity markets closed out 2023 with their highest quarterly returns this year, following a period of weakness. In the fourth quarter, the strategy returned 14.87% (gross) and 14.59% (net) […]
Chemed Corp (NYSE:CHE), a company that operates through its two wholly-owned subsidiaries, VITAS Healthcare Corporation and Roto-Rooter, recently witnessed an insider sale.
CINCINNATI, April 01, 2024--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, following the close of trading on the New York Stock Exchange.
Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Brian Judkins, Vice President and Chief Legal Officer of Chemed Corp (NYSE:CHE), has sold 11,158 shares of the company on March 20, 2024, according to a recent SEC filing.